Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: WHO

Research Roundup: FDA approves monthly injectable HIV treatment, US recommits to WHO and joins COVAX, and Eli Lilly says antibody can prevent COVID-19 infection
PATH/Evelyn Hockstein
January 25, 2021

Research Roundup: FDA approves monthly injectable HIV treatment, US recommits to WHO and joins COVAX, and Eli Lilly says antibody can prevent COVID-19 infection

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Quiz: Test your knowledge of NTD innovation
GHTC
January 21, 2021

Quiz: Test your knowledge of NTD innovation

How much do you know about combatting neglected tropical diseases? In recognition of World NTD Day on January 30, GHTC is testing our readers' knowledge of NTD innovation.

Anna Kovacevich GHTC
Read more
Six issues to watch in US global health R&D policy in 2021
IAEA imagebank, NLO Office, Syrian Arab Republic
January 5, 2021

Six issues to watch in US global health R&D policy in 2021

2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.
Marissa Chmiola GHTC
Read more
Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval
PATH/Rocky Prajapati
January 4, 2021

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: ACT Accelerator therapeutics priorities, COVID-19 vaccine agreements, and a potential nasal spray prevention method
PATH/Gabe Bienczycki
November 9, 2020

Research Roundup: ACT Accelerator therapeutics priorities, COVID-19 vaccine agreements, and a potential nasal spray prevention method

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: ACT Accelerator funding pledges, low-cost tests for LMICs, and early antibody cocktail trial results
PATH/Gabe Bienczycki
October 5, 2020

Research Roundup: ACT Accelerator funding pledges, low-cost tests for LMICs, and early antibody cocktail trial results

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: COVID-19 vaccine allocation plans, an at-home diagnostic, and positive results on a new treatment
PATH/Patrick McKern
September 21, 2020

Research Roundup: COVID-19 vaccine allocation plans, an at-home diagnostic, and positive results on a new treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Global pandemic preparedness panel urges increased support for R&D
Dean Calma / IAEA
September 17, 2020

Global pandemic preparedness panel urges increased support for R&D

The COVID-19 pandemic has revealed a collective failure to take pandemic prevention, preparedness, and response seriously and prioritize it appropriately, according to a report released by The Global Preparedness Monitoring Board. In their recommendations, the board underscores the importance of strengthening the global health R&D ecosystem to prepare for future threats. Here we breakdown what they said.

Philip Kenol GHTC
Read more
Research Roundup: AstraZeneca's UK trial resumes, new rapid antigen test, and US will not join global vaccine initiative
PATH/Thet Htoo
September 14, 2020

Research Roundup: AstraZeneca's UK trial resumes, new rapid antigen test, and US will not join global vaccine initiative

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: Countries sign on to global vaccine initiative, scientists call for COVID-19 challenge trials, and a new TB test profiles drug resistance
PATH/Aaron Joel Santos
July 20, 2020

Research Roundup: Countries sign on to global vaccine initiative, scientists call for COVID-19 challenge trials, and a new TB test profiles drug resistance

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: COVID-19 vaccine packaging, trials, and asymptomatic spread
Eric Sales/ Asian Development Bank
June 15, 2020

Research Roundup: COVID-19 vaccine packaging, trials, and asymptomatic spread

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Julien Rashid GHTC
Read more
Research Roundup: 5 finalist COVID-19 vaccines, convalescent plasma results, and new WHO access pool
NIAID
June 8, 2020

Research Roundup: 5 finalist COVID-19 vaccines, convalescent plasma results, and new WHO access pool

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Julien Rashid GHTC
Read more
WHO’s vital role in global R&D response to COVID-19
US Mission Geneva
May 22, 2020

WHO’s vital role in global R&D response to COVID-19

The COVID-19 crisis has demonstrated just how crucial multilateral conveners like WHO are to our collective health, prosperity, and security and the need for enhanced international cooperation and worldwide solidarity.

Philip Kenol GHTC
Read More
Research Roundup: Early data suggests COVID-19 patients are responding to remdesivir, Sanofi & GSK partner to develop coronavirus vaccine, and US halts payments to WHO
PATH/Gabe Bienczycki
April 20, 2020

Research Roundup: Early data suggests COVID-19 patients are responding to remdesivir, Sanofi & GSK partner to develop coronavirus vaccine, and US halts payments to WHO

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: Access to experimental COVID-19 drug paused, WHO to launch coronavirus drug trial, and Takeda's dengue vaccine shows promise in clinical trials
PATH/Gabe Bienczycki
March 23, 2020

Research Roundup: Access to experimental COVID-19 drug paused, WHO to launch coronavirus drug trial, and Takeda's dengue vaccine shows promise in clinical trials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Research Roundup: Coronavirus vaccine trial starts, second patient cured of HIV, and new collaboration fills data gap on use of antimalarials in pregnancy
PATH/Patrick McKern
March 16, 2020

Research Roundup: Coronavirus vaccine trial starts, second patient cured of HIV, and new collaboration fills data gap on use of antimalarials in pregnancy

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Research Roundup: WHO launches digital EML, coronavirus vaccine ready for testing, and coronavirus treatment study underway
PATH/Matthew Dakin
March 2, 2020

Research Roundup: WHO launches digital EML, coronavirus vaccine ready for testing, and coronavirus treatment study underway

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia
PATH/Matthew Dakin
February 24, 2020

Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs
PATH/Patrick McKern
February 17, 2020

Research Roundup: Ebola outbreak wanes, remdesivir prevents MERS coronavirus disease in monkeys, and Trump's budget would cut global health programs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
3 takeaways from the WHO Executive Board meeting
WHO
February 14, 2020

3 takeaways from the WHO Executive Board meeting

With the global health emergency of the novel coronavirus looming large, last week the global health community gathered in Geneva to kick off the World Health Organization (WHO) Executive Board (EB) meeting. GHTC was on the scene following the official agenda and delivering statements. Here are our top three takeaways from this year’s EB.

Philip Kenol GHTC
Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.
Header Photo: PATH/Evelyn Hockstein

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In